GlassScriptPhysician profile
James A Keeney
NPI 1104833540
$22,099.41
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,305 · 2021: $194 · 2022: $12.39 · 2023: $720 · 2024: $563 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,030 · Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,030.00 |
| Food and Beverage | $373.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $18,897.87 | 2019-2024 | Attune |
| Heron Therapeutics, INC. | $2,122.02 | 2019 | |
| Depuy Synthes Sales INC. | $755.11 | 2019-2023 | Velys, Attune |
| Zimmer Biomet Holdings, INC. | $210.89 | 2023-2025 | Persona |
| Heraeus Medical, LLC. | $47.96 | 2024 | |
| Stryker Corporation | $27.10 | 2023 | Mako |
| Merck Sharp & Dohme LLC | $22.88 | 2025 | Bridion |
| Smith+Nephew, INC. | $15.58 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Keeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.